Severe asthma is a complex and often debilitating condition marked by persistent symptoms despite the use of high-dose inhaled medications and other standard therapies. Individuals with severe asthma may experience frequent exacerbations, limited lung function, repeated use of oral steroids, and disruptions to sleep, work, and daily activities, placing a significant burden on overall health and quality of life.

Advances in clinical research have led to FDA-approved therapies designed specifically for severe asthma. Participation in clinical research may provide eligible individuals access to these advanced treatment options at no cost, while helping to advance care for others living with severe asthma.